Scientific Name: Atogepant
Brand Name: Qulipta
Company Owner: Not Available
Mechanism Of Action The currently accepted theory of migraine pathophysiology considers dysfunction of the central nervous system, in particular the trigeminal ganglion, to be the root cause behind the condition.
Description of the Drug: Atogepant is an oral CGRP antagonist used for the preventative therapy of episodic migraine headaches.
Protein Data Bank: Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB16098